Research presented at the 2025 Academy of Managed Care Pharmacy annual meeting analyzed real-world treatment outcomes for dermatologic conditions, specifically highlighting the efficacy of ...

Biosimilar adoption and market dynamics are reshaping managed care, with the Inflation Reduction Act impacting innovation and market incentives. Specialty pharmaceuticals, particularly GLP-1 drugs ...

Current observations and foresight into the world of biosimilars, GLP-1s, PBM and payer trends, according to Jeff Casberg, MS ...

The FDA has recently approved two new prophylactic treatments for people with hemophilia who develop antibodies to clotting factors.

Academy of Managed Care Pharmacy (AMCP) The mission of the Wilkes University Chapter of AMCP is to educate the students, university, and community about how insurance companies and other major ...